Journal of Immunology Research

Journal of Immunology Research / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 6073961 | https://doi.org/10.1155/2017/6073961

Ting Zhang, Malgorzata A. Garstka, Ke Li, "Corrigendum to “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease”", Journal of Immunology Research, vol. 2017, Article ID 6073961, 1 page, 2017. https://doi.org/10.1155/2017/6073961

Corrigendum to “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease”

Received10 Sep 2017
Accepted16 Oct 2017
Published01 Nov 2017

In the article titled “The Controversial C5a Receptor C5aR2: Its Role in Health and Disease” [1], there was an error in Table 4, where Jun/fos-A8△71–73 should be corrected to A8△71–73. The corrected table is as follows:


LigandSpecificityFunctionRefs

Jun/fos-A8
A8△71–73
C5 mutant peptides
Human and murine C5aR1 and C5aR2Antagonists—block binding of C5a and C5a
des Arg to C5aRs
[51]
P32, P59—C terminal peptides of C5ahC5aR2Agonists—strongly stimulate the association of hC5aR2 with β-arrestin 2[21, 127]
LukS-PV—protein from S. aureusHuman and rabbit C5aR1
Human, macaque, and rabbit C5aR2
Antagonist of C5a-induced activation of neutrophils[48, 128]
HIgCB—protein complex from S. aureusHuman, macaque, rabbit, and cow C5aRsAntagonist of C5a-induced activation of neutrophils[128, 129]

References

  1. T. Zhang, M. A. Garstka, and K. Li, “The controversial C5a receptor C5aR2: its role in health and disease,” Journal of Immunology Research, vol. 2017, Article ID 8193932, 16 pages, 2017. View at: Publisher Site | Google Scholar

Copyright © 2017 Ting Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views591
Downloads288
Citations

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.